| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Allarity Therapeutics A/S (ST: ALLR)
ALLR Technical Analysis
3
| As on 20th Dec 2021 ALLR STOCK Price closed @ 1.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.11 & Buy for SHORT-TERM with Stoploss of 1.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALLRSTOCK Price
| Open | 2.10 | Change | Price | % |
| High | 2.10 | 1 Day | -0.56 | -26.54 |
| Low | 1.55 | 1 Week | -0.79 | -33.76 |
| Close | 1.55 | 1 Month | -0.29 | -15.76 |
| Volume | 2292803 | 1 Year | -0.42 | -21.32 |
| 52 Week High 3.10 | 52 Week Low 0.64 | ||||
ST Sweden Most Active Stocks
| TANGI | 0.00 | % |
| FING-B | 0.08 | 0.00% |
| SBB-B | 4.00 | 1.78% |
| LUNE | 21.97 | 6.65% |
| SNM | 0.88 | 2.33% |
| DIABIO | 0.03 | 0.00% |
| WYLD | 0.02 | 0.00% |
| NIBE-B | 45.75 | 1.87% |
| HDW-B | 0.00 | % |
| EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| ALLR Daily Charts |
ALLR Intraday Charts |
Whats New @ Bazaartrend |
ALLR Free Analysis |
|
|
ALLR Important Levels Intraday
| RESISTANCE | 2.61 |
| RESISTANCE | 2.27 |
| RESISTANCE | 2.06 |
| RESISTANCE | 1.85 |
| SUPPORT | 1.25 |
| SUPPORT | 1.04 |
| SUPPORT | 0.83 |
| SUPPORT | 0.49 |
ALLR Forecast November 2024
| 4th UP Forecast | 3.27 |
| 3rd UP Forecast | 2.72 |
| 2nd UP Forecast | 2.38 |
| 1st UP Forecast | 2.04 |
| 1st DOWN Forecast | 1.06 |
| 2nd DOWN Forecast | 0.72 |
| 3rd DOWN Forecast | 0.38 |
| 4th DOWN Forecast | -0.17 |
ALLR Weekly Forecast
| 4th UP Forecast | 2.01 |
| 3rd UP Forecast | 1.86 |
| 2nd UP Forecast | 1.77 |
| 1st UP Forecast | 1.68 |
| 1st DOWN Forecast | 1.42 |
| 2nd DOWN Forecast | 1.33 |
| 3rd DOWN Forecast | 1.24 |
| 4th DOWN Forecast | 1.09 |
ALLR Forecast2024
| 4th UP Forecast | 7.18 |
| 3rd UP Forecast | 5.37 |
| 2nd UP Forecast | 4.26 |
| 1st UP Forecast | 3.14 |
| 1st DOWN Forecast | -0.04 |
| 2nd DOWN Forecast | -1.16 |
| 3rd DOWN Forecast | -2.27 |
| 4th DOWN Forecast | -4.08 |
Allarity Therapeutics A/S ( ST Sweden Symbol : ALLR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALLR Business Profile
Allarity Therapeutics A/S develops various therapeutic candidates for the treatment of cancer using drug-specific companion diagnostics (cDx) generated by its drug response predictor technology. Its lead therapeutic candidate is dovitinib, a second-generation pan-tyrosine kinase inhibitor with the ability to inhibit numerous classes of tumor-driving tyrosine kinases, including FGFR, VEGFR, PDGFR, c-Kit, Flt-3, and CSF-1. The company's therapeutic candidates also include stenoparib, selective inhibitor of the key DNA damage repair enzyme poly-ADP-ribose polymerase; and IXEMPRA, a selective microtubule inhibitor that interferes with cancer cell division through mitotic arrest. It also developing other therapeutic candidates comprising LiPlaCis, a targeted liposomal formulation of Cisplatin; 2X-111, a targeted liposomal formulation of Doxorubicin; and Irofulven, a DNA damaging agent. The company was founded in 2004 and is headquartered in Horsholm, Denmark. Address: Venlighedsvej 1, Horsholm, Denmark, 2970
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service